- Free to use with a free sign-up to save drug and interaction lists. Funded by advertising. No Pro subscription or price was found.
- Not disclosed
- Not disclosed
- —
- —
- NZ
- None stated. Listed as a reference for comparison.

Drugs.com Professional
by Drugsite Trust · NZ
Free drug reference for professionals: AHFS monographs, interaction checker, pill identifier, FDA alerts and shortages. No AI features described.
On this page
- Regulatory & Compliance0/22
No FDA clearance listed
- Clinical Integration0/26
No EHR integrations listed
- Evidence Strength0/27
No peer-reviewed coverage
- Vendor & Market10.9/21.6
Mid-tier funding and adoption
- Sentiment & Transparency3/15
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/12
No FDA clearance listed
- HIPAA / SOC2 / BAA0/10
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/14
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/8
None of the top-3 EHRs covered
- Bidirectional write-back0/4
No bidirectional write-back documented
- Peer-reviewed papers0/21
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/6
No RCT, meta-analysis, or systematic review
- Funding & adoption signal11/16
Mid-tier funding and adoption
- Years in market0/6
Founded year not recorded
- Clinician sentiment (Reddit)0/9
No clinician sentiment data available
- Pricing transparency3/6
Pricing on request, no public amounts
Strong free public tier + Pro $285/yr.
Drug database + interactions + IV compatibility + pill ID.
Bottom line
Drugs.com is a free, ad-supported drug reference. It offers an interaction checker, a pill identifier, prescribing information for more than 5,000 medications and a professional hub with AHFS monographs. It is owned by a New Zealand trust and paid for by advertising. In one study it flagged more interactions than Micromedex and in an SSRI study more than the other four checkers, and its severity ratings often disagree with Micromedex and Lexicomp. It is useful as a fast second look for a clinician and a weak sole source for alert decisions.
What is Drugs.com and who runs it?
Drugsite Limited, as trustee of the Drugsite Trust, owns and operates the site. The About page says it is "administered by two New Zealand Pharmacists," lists an address in Auckland, and says it is hosted in Dallas, Texas. It calls itself "the largest, most widely visited, independent medicine information website available on the Internet" and says it is not affiliated with any pharmaceutical company. Revenue comes from ads, with Healthline Networks for the consumer side and eHealthcare Solutions for the professional side.
What is in it?
The database is powered by ASHP, Cerner Multum and Micromedex content. The professional hub lists AHFS DI monographs, a natural product database, FDA alerts and drug shortages. The /pro/ section carries FDA prescribing information described as "official labeling, full prescribing details, and clinical pharmacology data for over 5,000 medications." A free sign-up lets users save drug and interaction lists. The site also runs a veterinary product database through DVMetrics, and its symptom checker uses Harvard Health content.
How accurate is the interaction checker?
Three published comparisons put numbers on it:
- A comparison of nine tools on 145 oral oncolytic drug pairs found Lexicomp and Drugs.com the top performers with no significant difference between them, while sensitivity across all tools ranged from 0.65 to 0.96.
- In metabolic syndrome drugs, Micromedex reported 724 interacting pairs and Drugs.com 1,122, and the two gave the same severity rating for 37.43% of pairs.
- A 2025 comparison of five checkers on SSRIs found Drugs.com reported the most interactions and agreed poorly with Lexi-Interact.
What does it cost?
It is free to use, with a free sign-up for saved lists.
The verdict
A pharmacist or physician who wants a quick interaction lookup, a pill identifier and the FDA label in one place at no cost gets that here, and in the oral oncolytic comparison its sensitivity matched Lexicomp's. A team writing alert rules from severity grades has a different problem, since the grades are where the studies show the gaps.
Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Free | — | — | Free to use with a free sign-up to save drug and interaction lists. Funded by advertising. No Pro subscription or price was found. |
Source: vendor pricing page. Last checked October 15, 2026.


